P.256 A RANDOMISED, CROSSOVER STUDY TO EVALUATE THE SAFETY AND THE PHARMACOKINETIC PROFILES OF A SINGLE ORAL DOSE (400 MG) OF AMORPHOUS RIFAXIMIN IN COMPARISON WITH A SINGLE ORAL DOSE (400 MG) OF NORMIX® (RIFAXIMIN POLYMORPH-α IN HEALTHY VOLUNTEERS

✍ Scribed by A. Marzo; S. Ismaili

• Book ID: 119633964
• Publisher: Elsevier Science
• Year: 2010
• Tongue: English
• Weight: 88 KB
• Volume: 42
• Category: Article
• ISSN: 1590-8658
• DOI: 10.1016/s1590-8658(10)60368-4